Transcoronary ethanol ablation for recurrent ventricular tachycardia after failed catheter ablation: An update

Circulation: Arrhythmia and Electrophysiology

Volumn 4, Issue 6, 2011, Pages 889-896

  Tokuda, Michifumi ^a   Sobieszczyk, Piotr ^a   Eisenhauer, Andrew C ^a   Kojodjojo, Pipin ^a   Inada, Keiichi ^a   Koplan, Bruce A ^a   Michaud, Gregory F ^a   John, Roy M ^a   Epstein, Laurence M ^a   Sacher, Frédéric ^b   Stevenson, William G ^a   Tedrow, Usha B ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Catheter ablation; Complication; Coronary artery; Ethanol; Outcome; Ventricular tachycardia

Indexed keywords

ADULT; ARTICLE; CATHETER ABLATION; COMPLETE HEART BLOCK; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QRS COMPLEX; RECURRENT DISEASE; TRANSCORONARY ETHANOL ABLATION; TREATMENT FAILURE; AGED; CHI SQUARE DISTRIBUTION; HEART BLOCK; HEART FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTOR; TIME; UNITED STATES;

ALCOHOL;

AGED; BOSTON; CATHETER ABLATION; CHI-SQUARE DISTRIBUTION; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; ETHANOL; HEART BLOCK; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; TACHYCARDIA, VENTRICULAR; TIME FACTORS; TREATMENT FAILURE;

EID: 84857069874     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.111.966283     Document Type: Article

References (18)

1. Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky, Jongnarangsin K, Kralovec S, Sediva L, Ruskin JN, Josephson ME. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357:2657-2665.
2. Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacrétaz E, Pitschner HF, Kautzner J, Schumacher B, Hansen PS. VTACH study group. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet. 2010;375:31-40.
3. Inoue H, Waller BF, Zipes DP. Intracoronary ethyl alcohol or phenol injection ablates aconitine-induced ventricular tachycardia in dogs. J Am Coll Cardiol. 1987;10:1342-1349. (Pubitemid 18004688)
4. Brugada P, de Swart H, Smeets JL, Bär FW, Wellens HJ. Termination of tachycardias by interrupting blood flow to the arrhythmogenic area. Am J Cardiol. 1988;62:387-392.
5. Brugada P, de Swart H, Smeets JL, Wellens HJ. Transcoronary chemical ablation of ventricular tachycardia. Circulation. 1989;79:475-482.
6. Kay GN, Epstein AE, Bubien RS, Anderson PG, Dailey SM, Plumb VJ. Intracoronary ethanol ablation for the treatment of recurrent sustained ventricular tachycardia. J Am Coll Cardiol. 1992;19:159-168.
7. Sacher F, Sobieszczyk P, Tedrow U, Eisenhauer AC, Field ME, Selwyn A, Raymond JM, Koplan B, Epstein LM, Stevenson WG. Transcoronary ethanol ventricular tachycardia ablation in the modern electrophysiology era. Heart Rhythm. 2008;5:62-68.
8. Soejima K, Stevenson WG, Sapp JL, Selwyn AP, Couper G, Epstein LM. Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars. J Am Coll Cardiol. 2004;43:1834-1842. (Pubitemid 38622524)
9. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130:461-470. (Pubitemid 29135798)
10. Goldfarb S, McCullough PA, McDermott J, Gay SB. Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology. Mayo Clin Proc. 2009;84:170-179.
11. Inada K, Seiler J, Roberts-Thomson KC, Steven D, Rosman J, John RM, Sobieszczyk P, Stevenson WG, Tedrow UB. Substrate characterization and catheter ablation for monomorphic ventricular tachycardia in patients with apical hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2011;22:41-48.
12. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, McGoon DC, Murphy ML, Roe BB. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation. 1975;51:5-40.
13. Bream PR, Souza AS Jr, Elliott LP, Soto B, Curry GC. Right superior septal perforator artery: its angiographic description and clinical significance. AJR Am J Roentgenol. 1979;133:67-73.
14. Werner GS, Ferrari M, Betge S, Gastmann O, Richartz BM, Figulla HR. Collateral function in chronic total coronary occlusions is related to regional myocardial function and duration of occlusion. Circulation. 2001;104:2784-2790. (Pubitemid 33126651)
15. Hallen J, Buser P, Schwitter J, Petzelbauer P, Geudelin B, Fagerland MW, Jaffe AS, Atar D. Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction. Am J Cardiol. 2009;104: 1472-1477.
16. Wu E, Ortiz JT, Tejedor P, Lee DC, Bucciarelli-Ducci C, Kansal P, Carr JC, Holly TA, Lloyd-Jones D, Klocke FJ, Bonow RO. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart. 2008;94:730-736. (Pubitemid 351744690)
17. Knight C, Kurbaan AS, Seggewiss H, Henein M, Gunning M, Harrington D, Fassbender D, Gleichmann U, Sigwart U. Nonsurgical septal reduction in hypertrophic obstructive cardiomyopathy. Outcome in the first series of patients. Circulation. 1997;95:2075-2081. (Pubitemid 27184276)
18. Chang SM, Nagueh SF, Spencer WH III, Lakkis NM. Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy. J Am Coll Cardiol. 2003;42:296-300. (Pubitemid 36851421)